157 related articles for article (PubMed ID: 10027727)
1. The difference in NK-cell activity between patients with non-Hodgkin's lymphomas and Hodgkin's disease.
Konjević G; Jurisić V; Banićevic B; Spuzić I
Br J Haematol; 1999 Jan; 104(1):144-51. PubMed ID: 10027727
[TBL] [Abstract][Full Text] [Related]
2. Different alterations in lactate dehydrogenase activity and profile of peripheral blood mononuclear cells in Hodgkin's and non-Hodgkin's lymphomas.
Jurisić V; Konjević G; Banićević B; Duricić B; Spuzić I
Eur J Haematol; 2000 Apr; 64(4):259-66. PubMed ID: 10776698
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immunity in children with Hodgkin's and non-Hodgkin's lymphomas.
Eckschlager T; Jira M; Strejcek J
Pediatr Hematol Oncol; 1991; 8(3):251-6. PubMed ID: 1742184
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
5. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas.
Jaffe ES; Zarate-Osorno A; Kingma DW; Raffeld M; Medeiros LJ
Ann Oncol; 1994; 5 Suppl 1():7-11. PubMed ID: 8172822
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
7. Non-Hodgkin's lymphoma: natural cell-mediated cytotoxicity correlated with histological classification and prognosis.
Mehta B; Advani S; Nadkarni J
Oncology; 1989; 46(5):323-5. PubMed ID: 2779947
[TBL] [Abstract][Full Text] [Related]
8. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
[TBL] [Abstract][Full Text] [Related]
10. [Non-Hodgkin's lymphoma: morphologic, immunologic and cytogenetic classification].
Ristić S; Jovanović V; Ristić S; Radojković M
Srp Arh Celok Lek; 1996; 124(9-10):276-82. PubMed ID: 9102863
[TBL] [Abstract][Full Text] [Related]
11. [Activity of natural cytotoxic cells in non-Hodgkin's lymphoma].
Frydecka I; Kotlarek-Haus S; Kuliczkowski K; Kuliszkiewicz-Janus M
Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):357-9. PubMed ID: 1437753
[TBL] [Abstract][Full Text] [Related]
12. Serum lactate dehydrogenase isoenzyme pattern in non-Hodgkin's lymphomas.
Ricerca BM; Storti S; Campisi S; Pagano L; Dalla Torre F; Marra R; Amato A; Mango G; Bizzi B
Int J Biol Markers; 1988; 3(4):237-42. PubMed ID: 3235851
[TBL] [Abstract][Full Text] [Related]
13. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.
Jaffe ES; Zarate-Osorno A; Medeiros LJ
Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852
[TBL] [Abstract][Full Text] [Related]
14. Low natural killer cell activity in patients with malignant lymphoma.
Tursz T; Dokhelar MC; Lipinski M; Amiel JL
Cancer; 1982 Dec; 50(11):2333-5. PubMed ID: 6958348
[TBL] [Abstract][Full Text] [Related]
15. Natural killer activity in spleens and lymph nodes from patients with Hodgkin's disease.
Ruco LP; Procopio A; Uccini S; Marcorelli E; Baroni CD
Cancer Res; 1982 May; 42(5):2063-8. PubMed ID: 6175405
[TBL] [Abstract][Full Text] [Related]
16. TNF-alpha induces changes in LDH isotype profile following triggering of apoptosis in PBL of non-Hodgkin's lymphomas.
Jurisic V; Bumbasirevic V; Konjevic G; Djuricic B; Spuzic I
Ann Hematol; 2004 Feb; 83(2):84-91. PubMed ID: 14586559
[TBL] [Abstract][Full Text] [Related]
17. Expression of intercellular adhesion molecule-3 (ICAM-3/CD50) in malignant lymphoproliferative disorders and solid tumors.
Terol MJ; Cid MC; López-Guillermo A; Juan M; Yagüe J; Miralles A; Vilella R; Vives J; Cardesa A; Montserrat E; Campo E
Tissue Antigens; 1996 Oct; 48(4 Pt 1):271-7. PubMed ID: 8946680
[TBL] [Abstract][Full Text] [Related]
18. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
19. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
[TBL] [Abstract][Full Text] [Related]
20. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
